FibroBiologics, Inc. Financial Overview
FibroBiologics, Inc.'s market cap is currently $18.08M. The company's EPS TTM is $-0.13; its P/E ratio is -0.57; FibroBiologics, Inc. is scheduled to report earnings on October 31, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
